tiprankstipranks
Insulet (PODD)
NASDAQ:PODD
US Market
PODD
Insulet
RESEARCH TOOLSreports
Want to see PODD full AI Analyst Report?

Insulet (PODD) Stock News & Sentiment

1,100 Followers
Insulet’s EVOLUTION T1D Trial Signals Next Step in Automated Insulin Delivery
Premium
Company Announcements
Insulet’s EVOLUTION T1D Trial Signals Next Step in Automated Insulin Delivery
2d ago
PODD
Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects and Misleading Safety Claims
Premium
Class Action
Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects and Misleading Safety Claims
2d ago
PODD
PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action – Contact Levi & Korsinsky
Premium
Class Action
PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action – Contact Levi & Korsinsky
5d ago
PODD
Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects in Omnipod Products 
Premium
Class Action
Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects in Omnipod Products 
11d ago
PODD
Insulet’s EVOLVE Trial Targets Big Type 2 Diabetes Opportunity With Omnipod M
Premium
Company Announcements
Insulet’s EVOLVE Trial Targets Big Type 2 Diabetes Opportunity With Omnipod M
17d ago
PODD
Omnipod 6 vs. Omnipod 5: A Fresh Clinical Look at Insulet’s Next Growth Catalyst
Premium
Company Announcements
Omnipod 6 vs. Omnipod 5: A Fresh Clinical Look at Insulet’s Next Growth Catalyst
17d ago
PODD
Insulet’s Optimal-B Study: Real-World Omnipod 5 Data Investors Should Watch
Premium
Company Announcements
Insulet’s Optimal-B Study: Real-World Omnipod 5 Data Investors Should Watch
17d ago
PODD
More PODD News >

PODD News on the Web

PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action – Contact Levi & Korsinsky
TipRanks News
Bearish
Insulet partners with Calm to provide resources for people living with diabetes
TipRanks News
Bearish
Insulet price target lowered to $210 from $219 at Truist
TipRanks News
Bearish
Insulet price target lowered to $225 from $250 at Stifel
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Insulet (PODD)
TipRanks News
Bullish
Insulet (PODD) Faces Class I Recall of Omnipod Insulin Pump System
GuruFocus News
Bearish
FDA says Insulet recalled certain Omnipod Pods
TipRanks News
Bearish
Insulet appoints Mazelsky to its Board of Directors
TipRanks News
Neutral

News Score - Last 7 Days

Very Negative
PODD
Sector Average
Media Buzz
This Week8 articles
Weekly Average5.5 articles
News Sentiment
This Week17%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PODD’s Media Buzz Sentiment?
8 articles about PODD were published this week. In an average week, 5.5 articles are published.
    What is PODD’s weekly average amount of articles?
    In an average week, 5.5 articles about PODD are published.
      What is PODD’s News Sentiment?
      17% of articles about PODD were positive this week, compared to its sector average of 89%.
        Healthcare Stocks that are Trending in the News
        DBVTDBV Technologies SA - American
        CDNACareDx
        TRVITrevi Therapeutics
        ANIPANI Pharmaceuticals
        LOVFFCannara Biotech
        Showing the stocks with the most bullish news sentiment over the past week